Adolor (ADLR) Reports Q4 Loss of $0.33, Misses by 3c
More News related to ADLR
- Adolor Corp. (ADLR) Posts Q3 Loss of $0.24, Misses Estimates
- Adolor Corporation Reports Third Quarter 2009 Financial Results
- Trading Radar for 10/29: Exxon (XOM), Motorola (MOT), Waste Management (WM) Report
- Adolor Corporation to Host Investor Conference Call To Report Third Quarter 2009 Financial Results
- After-Hours Movers 9/21: OCLR, CIM, ADLR Higher; AMR, DDRX, FSX, LPX, EPD, LINC Lower
More News related to Earnings
- Hemispherx Biopharma (HEB) Reports a Q3 Loss; Comments on FDA Responses
- Wright Medical Group (WMGI) Announces FDA Approval For CONSERVE Plus Total Hip Resurfacing System
- Vascular Solutions (VASC) Receives 501(k) Clearance from U.S. FDA for GuideLiner Catheter
- Glaxo (GSK) and XenoPort (XNPT) Announed that U.S. FDA Has Extended the Review Date of GSK1838262/XP13512
- Compugen (CGEN) Announces Discovery of Biomarker CGEN-40001 for Type 2 Diabetes
Adolor Corporation (Nasdaq: ADLR) reports Q4 loss of $0.33, 3 cents worse than the analyst estimate of ($0.30). Revenues for the quarter were $8.41 million, versus the consensus of $8.03 million.
Related Categories
EarningsStocks Mentioned
-0.01Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
